Mark McCarthy

Mark McCarthy is Executive Director of Human Genetics, and Principal Fellow at Genentech. Prior to 2019, he was Robert Turner Professor of Diabetes Medicine at the University of Oxford where his academic research focused on genetic and genomic analysis of type 2 diabetes and related traits, including obesity and birthweight. In industry, he applies knowledge and insights gathered from research and clinical practice to deliver improved strategies for target identification and validation, risk stratification and biomarker discovery so as to bring new medicines to patients.